#1 Clinical Trials Search in Europe

Fenofibrate

Fenofibrate, a medication primarily used to lower cholesterol and triglyceride levels, has been the subject of numerous clinical trials exploring its potential benefits in various medical conditions. These trials aim to evaluate the drug’s efficacy, safety, and potential new applications in treating diseases such as diabetes, kidney problems, and cholestasis. This article summarizes the key findings from recent clinical trials involving fenofibrate.

Table of Contents

What is Fenofibrate?

Fenofibrate is a medication primarily used to treat high levels of lipids (fats) in the blood, particularly triglycerides. It belongs to a class of drugs called fibrates[1]. This medication is known by several brand names, including Lipanthyl, Tricor, Triglide, and Antara[2]. Fenofibrate is often prescribed alongside other cholesterol-lowering medications, such as statins, to help manage complex lipid disorders[3].

Conditions Treated by Fenofibrate

Fenofibrate is used to treat several conditions related to abnormal lipid levels in the blood:

  • Hypertriglyceridemia: This is a condition where there are high levels of triglycerides in the blood. Fenofibrate helps to lower these levels[1].
  • Type 2 Diabetes: While not a direct treatment for diabetes, fenofibrate is often used in diabetic patients to manage the lipid abnormalities that frequently occur with this condition[2].
  • Dyslipidemia: This term refers to an imbalance of lipids in the blood, including high cholesterol and triglycerides. Fenofibrate helps to correct these imbalances[4].
  • Cholestasis: Some research is exploring the use of fenofibrate in treating cholestasis, a condition where bile flow from the liver is reduced or blocked[5].

How Fenofibrate Works

Fenofibrate works by activating a protein in the body called peroxisome proliferator-activated receptor alpha (PPARα). This protein plays a crucial role in regulating the metabolism of fats in the body. By activating PPARα, fenofibrate helps to[6]:

  • Decrease the production of triglycerides in the liver
  • Increase the breakdown of fatty acids
  • Raise levels of HDL (good) cholesterol
  • Lower levels of LDL (bad) cholesterol

Dosage and Administration

Fenofibrate is typically taken orally once daily. The dosage can vary depending on the specific condition being treated and the formulation of the medication. Common dosages include:

  • 145 mg or 160 mg tablets taken once daily[4]
  • 200 mg capsules taken once daily with breakfast[6]

It’s important to take fenofibrate exactly as prescribed by your healthcare provider. The medication is often taken with food to increase its absorption.

Potential Benefits of Fenofibrate

Research has shown that fenofibrate may offer several benefits beyond just lowering triglycerides:

  • Diabetic Retinopathy: Some studies suggest that fenofibrate may help protect against eye damage in people with diabetes[2].
  • Kidney Protection: Fenofibrate may help slow the progression of kidney damage in people with type 2 diabetes[6].
  • Liver Health: There is ongoing research into whether fenofibrate could help prevent certain liver complications after transplantation[7].

Side Effects and Safety Considerations

Like all medications, fenofibrate can cause side effects. Common side effects may include:

  • Stomach pain or nausea
  • Headache
  • Back pain
  • Abnormal liver function tests

More serious side effects, though rare, can include muscle pain or weakness, which could be a sign of a serious muscle problem. It’s important to inform your doctor of any side effects you experience[7].

Fenofibrate can interact with other medications, particularly certain statins. Always inform your healthcare provider about all medications you’re taking[3].

Ongoing Research and Future Prospects

Researchers continue to explore new potential uses for fenofibrate:

  • Type 1 Diabetes: A study is investigating whether fenofibrate could help preserve insulin production in children newly diagnosed with type 1 diabetes[8].
  • Pregnancy: Research is being conducted to evaluate the safety of fenofibrate in pregnant women with severe hypertriglyceridemia[9].
  • Liver Transplantation: A study is assessing whether fenofibrate could help prevent complications after certain types of liver transplants[7].

These ongoing studies highlight the potential for fenofibrate to play a role in treating a wider range of conditions in the future. However, it’s important to remember that more research is needed before these new uses can be confirmed and approved.

Study Focus Key Findings/Objectives Patient Population
Type 1 Diabetes Evaluating fenofibrate’s effect on beta-cell function in children with newly diagnosed type 1 diabetes Children and adolescents with new diagnosis of type 1 diabetes
Hypertriglyceridemia Assessing the efficacy and safety of fenofibrate in combination with omega-3 fatty acids Adults with very high triglyceride levels
Type 2 Diabetes Investigating fenofibrate’s impact on microalbuminuria and lipid profiles Adults with type 2 diabetes and hypertriglyceridemia
Pregnancy Safety Evaluating the safety of fenofibrate use during pregnancy in women with severe hypertriglyceridemia Pregnant women with triglyceride levels >10mM
Pediatric Cholestasis Assessing fenofibrate’s effect on pruritus and biochemical markers in children with cholestatic liver diseases Children with chronic cholestasis

FAQ

  • What is fenofibrate used for in clinical trials? Fenofibrate is being studied in clinical trials for various conditions, including type 1 and type 2 diabetes, hypertriglyceridemia, microalbuminuria, and cholestasis in children. Researchers are exploring its potential benefits beyond its primary use as a lipid-lowering medication.
  • How does fenofibrate affect diabetes? Clinical trials are investigating fenofibrate's effects on diabetes, particularly its potential to prolong residual beta-cell function in children with newly diagnosed type 1 diabetes and its impact on microalbuminuria in patients with type 2 diabetes. Some studies suggest it may help protect against diabetes-associated microvascular complications.
  • Is fenofibrate safe to use during pregnancy? A clinical trial is currently evaluating the safety of fenofibrate in pregnant women with severe hypertriglyceridemia. The study aims to assess its effects on pregnancy outcomes and infant growth, as well as its placental transfer and milk penetration.
  • Can fenofibrate be used in combination with other medications? Several clinical trials are exploring the use of fenofibrate in combination with other drugs, such as statins and omega-3 fatty acids. These studies aim to evaluate the safety and efficacy of these combinations in treating various lipid disorders.
  • What are the potential side effects of fenofibrate in clinical trials? Clinical trials are monitoring for potential side effects of fenofibrate, including changes in liver function tests, lipid profiles, and serum creatinine levels. Some studies have noted temporary increases in creatinine levels, which appear to reverse after discontinuation of the medication.

Ongoing Clinical Trials on Fenofibrate

  • Study Comparing Rosuvastatin and Fenofibrate with Pravastatin and Fenofibrate for Patients with Mixed Dyslipidemia at High Risk of Heart Disease

    Recruiting

    1 1 1 1
    Investigated drugs:
    Greece

  • Study on the Effectiveness of Bevacizumab and Drug Combination for Children with Recurrent or Progressive Medulloblastoma, Ependymoma, and ATRT

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Czechia Denmark France Norway Spain +1

Glossary

  • Fenofibrate: A medication used to lower cholesterol and triglyceride levels in the blood. It belongs to a class of drugs called fibrates and works by increasing the breakdown of fatty substances in the body.
  • Hypertriglyceridemia: A condition characterized by high levels of triglycerides (a type of fat) in the blood, which can increase the risk of heart disease and pancreatitis.
  • Microalbuminuria: The presence of small amounts of albumin (a protein) in the urine, which can be an early sign of kidney damage, especially in people with diabetes.
  • C-peptide: A substance produced by the pancreas along with insulin. Measuring C-peptide levels can help determine how much insulin the body is producing.
  • Cholestasis: A condition where the flow of bile from the liver is reduced or blocked, leading to accumulation of bile acids and other substances in the blood.
  • Pharmacokinetics: The study of how a drug is absorbed, distributed, metabolized, and eliminated by the body over time.
  • AUC (Area Under the Curve): A measure used in pharmacokinetics to represent the total exposure to a drug over time, typically used to compare different formulations or doses of a medication.
  • Placebo: An inactive substance or treatment used in clinical trials as a control to compare against the effects of the drug being studied.

References

  1. https://clinicaltrials.gov/study/NCT00246636
  2. https://clinicaltrials.gov/study/NCT03829514
  3. https://clinicaltrials.gov/study/NCT02651753
  4. https://clinicaltrials.gov/study/NCT00613613
  5. https://clinicaltrials.gov/study/NCT03586674
  6. https://clinicaltrials.gov/study/NCT02314533
  7. https://clinicaltrials.gov/study/NCT05514119
  8. https://clinicaltrials.gov/study/NCT05909800
  9. https://clinicaltrials.gov/study/NCT05883865